| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/23/1994 | CA2151257A1 Dna encoding chitin deacetylase |
| 06/23/1994 | CA2151234A1 Serum pyridinium crosslinks assay |
| 06/23/1994 | CA2151128A1 Hepatitis c virus (hcv) non-structural-3 peptides, antibodies thereto and methods for the detection of hcv |
| 06/23/1994 | CA2151126A1 Peptides from the c33 region of hcv, antibodies thereto and methods for the detection of hcv |
| 06/23/1994 | CA2150935A1 Clostridial toxin disease therapy |
| 06/23/1994 | CA2150680A1 A petroleum immunoassay method, its components and a kit for use in performing the same |
| 06/23/1994 | CA2148132A1 Immunoassay for the measurement of collagen cleavage in cartilage |
| 06/23/1994 | CA2128544A1 Humanised antibodies directed against a33 antigen |
| 06/23/1994 | CA2112046A1 Antibodies, polypeptides, production and use thereof |
| 06/23/1994 | CA2110852A1 Monoclonal antibodies that define a unique antigen of human b cell receptor complex and methods of using same for diagnosis and treatment |
| 06/22/1994 | EP0602899A2 Modified proteins containing controllable intervening sequences and methods of their production |
| 06/22/1994 | EP0602761A1 Prevention and treatment of retroviral disease |
| 06/22/1994 | EP0602687A1 Modified VP1/P2A regions of rhinovirus systems |
| 06/22/1994 | EP0602601A2 Stable antibody solution and stabilization of antibody |
| 06/22/1994 | EP0602248A1 Monoclonal antibody against human lung surfactant apoprotein d and use thereof |
| 06/22/1994 | EP0602178A1 T cell receptor-based therapy for rheumatoid arthritis |
| 06/22/1994 | EP0602126A1 Immunoglobulin variants for specific fc epsilon receptors |
| 06/22/1994 | EP0602079A1 POLYPEPTIDES CAPABLE OF $i(IN VIVO) INDUCTION OF ANTIBODIES THEMSELVES CAPABLE OF INHIBITING THE INVASION OF RED BLOOD CORPUSCLES BY MEROZOITES OF $i(P.FALCIPARUM), RELATED PRODUCTS AND THEIR USE IN PRODUCING VACCINE COMPOSITIONS |
| 06/22/1994 | EP0602046A1 Detection of feline immunodeficiency viruses |
| 06/22/1994 | EP0545951B1 Hrsv vaccine |
| 06/22/1994 | EP0497757B1 E. coli secretory strains |
| 06/22/1994 | EP0470136B1 Therapeutic agent |
| 06/22/1994 | EP0409895B1 A pasteurella vaccine |
| 06/22/1994 | EP0302887B1 Bacterial antigens, antibodies, vaccines, and methods of manufacture |
| 06/22/1994 | EP0176588B1 Platelet related growth regulator |
| 06/22/1994 | CN1088210A Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
| 06/21/1994 | US5322936 Nucleic acids encoding trypanosoma cruzi heparin-binding protein |
| 06/21/1994 | US5322837 Stimulating production of red blood cells |
| 06/21/1994 | US5322788 Monoclonal anti-body to cell surface protein of the bacterium Streptococcus pneumoniae |
| 06/21/1994 | US5322769 Methods for using CKS fusion proteins |
| 06/21/1994 | US5322678 Alteration of pharmacokinetics of proteins by charge modification |
| 06/18/1994 | CA2111603A1 Stable antibody solution and stabilization of antibody |
| 06/15/1994 | EP0601859A2 Pharmaceutic composition comprising cancer-related antibodies |
| 06/15/1994 | EP0601360A1 Progenitor B cell stimulating factor |
| 06/15/1994 | EP0601135A1 Osteogenic proteins in the treatment of bone diseases |
| 06/15/1994 | EP0601129A1 Morphogenic protein screening method |
| 06/15/1994 | EP0601125A1 V$g(a)12.1 T-CELL RECEPTOR-SPECIFIC REAGENTS FOR DIAGNOSING AND TREATING RHEUMATOID ARTHRITIS |
| 06/15/1994 | EP0601106A1 Morphogen-induced modulation of inflammatory response |
| 06/15/1994 | EP0601043A1 Hybrid cytokines |
| 06/15/1994 | EP0600970A1 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 06/15/1994 | EP0600951A1 Diagnostic method for alzheimer's disease |
| 06/15/1994 | EP0469045B1 SYNTHETIC $i(PSEUDOMONAS) $i(AERUGINOSA) PILIN PEPTIDE AND RELATED VACCINES AND DIAGNOSTICS |
| 06/14/1994 | US5321142 Compounds from biopolymers and effector substances which are linked via optically active amino acid derivatives, processes for the preparation thereof and the use thereof |
| 06/14/1994 | US5321123 Protein S polypeptides and anti-peptide antibodies that inhibit protein S binding to C4B binding protein, diagnostic systems and therapeutic methods |
| 06/14/1994 | US5320970 Detection of collagen degradation in vivo |
| 06/14/1994 | US5320956 Ovarian, esophageal and cervical carcinomas |
| 06/14/1994 | US5320942 Detecting pancreatic cells |
| 06/14/1994 | US5320941 DNA sequence encoding mas onhcogene, polypeptides encoded therefrom and diagnostic and other methods based therefrom |
| 06/12/1994 | CA2110934A1 Human cns receptors of the nmda-r1 family |
| 06/10/1994 | CA2110543A1 Peg hydrazone and peg oxime linkage forming reagents and protein derivatives thereof |
| 06/09/1994 | WO1994012668A1 Mammalian muscle nad:arginine adp-ribosyltransferase |
| 06/09/1994 | WO1994012661A1 Anti-feline herpesvirus-1 recombinant antibody and gene fragment coding for said antibody |
| 06/09/1994 | WO1994012660A1 06-methylguanine-dna-methyltransferase (mgmt) specific antibodies |
| 06/09/1994 | WO1994012658A1 Process for producing foreign protein |
| 06/09/1994 | WO1994012641A1 Haemophilus outer membrane protein |
| 06/09/1994 | WO1994012635A2 Novel seven transmembrane receptors |
| 06/09/1994 | WO1994012631A1 Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors |
| 06/09/1994 | WO1994012626A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins |
| 06/09/1994 | WO1994012625A2 LIGAND BINDING VARIABLE DOMAIN (V-MIN) COMPRISING A FRAMEWORK REGION WITH A CYCLICALLY PERMUTED CENTRAL β-BARREL |
| 06/09/1994 | WO1994012618A1 PURIFICATION, COMPOSITION AND SPECIFICITY OF HEPARINASE I, II, AND III FROM $i(FLAVOBACTERIUM HEPARINUM) |
| 06/09/1994 | WO1994012535A1 Progenitor b cell stimulating factor |
| 06/09/1994 | WO1994012531A1 Antagonists of human gamma interferon |
| 06/09/1994 | WO1994012529A1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome |
| 06/09/1994 | WO1994012521A1 Cellular genes encoding retinoblastoma-associated proteins |
| 06/09/1994 | WO1994012520A1 Linker for linked fusion polypeptides |
| 06/09/1994 | WO1994012215A1 Humanized antibodies reactive with l-selectin |
| 06/09/1994 | WO1994012214A1 Humanized antibodies reactive with cd18 |
| 06/09/1994 | WO1994012210A1 Anti-edlf antibody, composition thereof and method of diagnosing and treating cardiac arrhythmias, hypertension |
| 06/09/1994 | WO1994012202A1 ACTIVATION OF p53 PROTEIN |
| 06/09/1994 | WO1994012196A1 Conjugates and constructs including anti-cd28 and anti-cd3 binding molecules |
| 06/09/1994 | WO1994012144A2 Treatment of infertility and enhancement of fertilization capacity in mammalian males |
| 06/09/1994 | WO1994004565A3 Ipnv vaccine |
| 06/09/1994 | WO1994004180A3 Novel uses of il-4 and/or il-10, and antibodies against the same |
| 06/09/1994 | DE4240801A1 Staphylo-kinase (SAK) sequences lacking sequences for signal peptide(s) |
| 06/09/1994 | CA2149889A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins |
| 06/09/1994 | CA2149883A1 Cellular genes encoding retinoblastoma-associated proteins |
| 06/09/1994 | CA2149867A1 O6-methylguanine-dna-methyltransferase (mgmt) specific antibodies |
| 06/09/1994 | CA2149785A1 Antagonists of human gamma interferon |
| 06/09/1994 | CA2149763A1 Progenitor b cell stimulating factor |
| 06/09/1994 | CA2149635A1 Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors |
| 06/09/1994 | CA2149025A1 Humanized antibodies reactive with l-selectin |
| 06/08/1994 | EP0600396A2 Intestinal protozoal vaccines |
| 06/08/1994 | EP0600326A2 Antigen peptide of streptolysin O and method of determination of streptolysin antibody |
| 06/08/1994 | EP0600018A1 Hepatitis c assay utilizing recombinant antigens to c-100 region |
| 06/08/1994 | EP0600000A1 Hepatitis c assay utilizing recombinant antigens from ns5 region |
| 06/08/1994 | EP0599935A1 Reagents and methods for the quantification of amitriptyline or nortriptyline in biological fluids |
| 06/08/1994 | EP0599913A1 Monoclonal antibodies to putative hcv ns5 proteins and methos for using same |
| 06/08/1994 | EP0599845A1 Medicament containing an agent inhibiting in vivo pathological apoptosis and applications thereof |
| 06/08/1994 | EP0553287A4 Cytokine-induced marker for inflammatory response |
| 06/08/1994 | EP0531300B1 Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy |
| 06/08/1994 | EP0495896B1 Vaccines for protecting against infections by hiv virus;process for producing the same and their use as diagnostic and immunotherapy means |
| 06/08/1994 | CN1087681A Novel antibodies for conferring passive immunity against infection by a pathogen in humans |
| 06/07/1994 | US5319072 Human antithrombin-III preparation |
| 06/07/1994 | US5318982 Inhibiting crosslinking of proteins |
| 06/07/1994 | US5318897 Monoclonal antibody and antibody components elicited to a polypeptide antigen ground state |
| 06/07/1994 | US5318890 Assays for inhibitors of leukocyte adhesion |
| 06/07/1994 | CA1330050C Enrichment and concentration of proteins by ultrafiltration |
| 06/07/1994 | CA1330038C Methods and compositions for the use of hiv env polypeptides and antibodies thereto |
| 06/01/1994 | EP0599822A2 Method of preparation and use for zona pellucida antigens for sterilization and contraception |
| 06/01/1994 | EP0599274A1 HER4, a human receptor tyrosine kinase of the epidermal growth factor receptor family |